Interpace Biosciences Inc (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,372 | 2,321 | 6,068 | 15,199 | 602 |
| Receivables | 8,028 | 10,338 | 9,483 | 3,437 | 2,209 |
| Other current assets | 2,722 | 3,851 | 2,170 | 1,172 | 1,429 |
| TOTAL | $14,122 | $16,510 | $17,721 | $19,808 | $4,240 |
| Non-Current Assets | |||||
| PPE Net | 7,349 | 6,814 | 837 | 654 | 929 |
| Intangibles | 19,784 | 24,282 | 12,538 | 33,105 | 36,358 |
| Other Non-Current Assets | 4,426 | 3,934 | 31 | 31 | 251 |
| TOTAL | $31,559 | $35,030 | $13,406 | $33,790 | $37,538 |
| Total Assets | $45,681 | $51,540 | $31,127 | $53,598 | $41,778 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,511 | 4,709 | 1,059 | 391 | 2,326 |
| Accrued Expenses | 3,161 | 2,341 | 1,544 | 1,394 | 3,551 |
| TOTAL | $18,233 | $17,292 | $8,669 | $8,091 | $16,241 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 3,000 | N/A | N/A | 7,908 |
| Other Non-Current Liabilities | 56,531 | 35,727 | 7,012 | 5,638 | 11,098 |
| TOTAL | $56,531 | $38,727 | $7,012 | $5,638 | $19,006 |
| Total Liabilities | $74,764 | $56,019 | $15,681 | $13,729 | $35,247 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,112 | 4,044 | 3,810 | 2,787 | 672 |
| Common Shares | 402 | 393 | 287 | 278 | 22 |
| Retained earnings | -212,116 | -185,665 | -158,981 | -131,800 | -119,584 |
| Other shareholders' equity | 227 | 279 | 320 | 329 | 357 |
| TOTAL | $-29,083 | $-4,479 | $15,446 | $39,869 | $6,531 |
| Total Liabilities And Equity | $45,681 | $51,540 | $31,127 | $53,598 | $41,778 |